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ABSTRACT 
Network bioinformatics and web-based data collection instruments have the capacity to improve 
the efficiency of the UK’s appropriately high levels of investment into cardiovascular research. 
A very large proportion of scientific data falls into the long-tail of the cardiovascular research 
distribution curve, with numerous small independent research efforts yielding a rich variety of 
specialty data sets. The merging of such myriad datasets and the eradication of data silos, plus 
linkage with outcomes could be greatly facilitated through the provision of a national set of 
standardised data collection instruments—a shared-cardioinformatics library of tools designed 
by and for clinical academics active in the long-tail of biomedical research. Across the 
cardiovascular research domain, like the rest of medicine, the national aggregation and 
democratization of diverse long-tail data is the best way to convert numerous small but 
expensive cohort data sources into big data, expanding our knowledge-base, breaking down 
translational barriers, improving research efficiency and with time, improving patient outcomes.  
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MAIN TEXT 
Background 
Within clinical research institutions across the UK currently, only a small proportion of 
generated data is effectively being captured and safely stored long term; research efforts are 
fragmented and the challenges of multi-centre collaboration are not yet overcome. A shared 
national initiative of accessible and secure bioinformatics solutions tailored to the needs of 
junior and senior clinical-academics has the potential to address this unmet need and 
cardiovascular research provides a clear example.  
Cardiovascular disease is a leading public health problem and a number one killer in the UK 
accounting for 40% of all national deaths and costing the UK economy £29bn a year in 
healthcare expenditure and lost productivity. The UK spends more of its healthcare budget on 
cardiovascular disease and research than any other EU economy[1,2]. Over the last 20 years, 
there has been an explosive growth in cardiovascular investigations, imaging and therapies 
across the National Health Service (NHS) underpinning clinical care but also the >£117 million 
annual research investment[3] that creates expensive clinical cohorts[4]. There is a pressing 
need to merge and curate (for at least 10 years) not only the large well-organised big cardiac 
science datasets[5–8] but also the richly diverse and heterogeneous smaller cohort data sets 
produced by small groups and individual cardiologists, the so-called long-tail data[9] (Figs. 1 
and 2)—the large proportion of scientific data that falls into the long-tail of the distribution 
curve[10]; a product of the numerous small independent research efforts yielding a rich variety 
of specialty cardiac research data sets. The extreme right portion of the long-tail includes 
unpublished dark data: siloed databases locked up in applications, null findings, laboratory 
notes, log archives, untagged image files, animal care records, etc.[9] Dark data in cardiology 
can be illuminating but it is often inaccessible to the outside world. The merging of such myriad 
datasets and the eradication of data silos, plus linkage with outcomes could be greatly facilitated 
through the provision of a national set of standardised data collection instruments—a shared-
cardioinformatics library of tools designed by and for clinical academics active in the long-tail 
of cardiovascular research. Such bioinformatics set-up costs are high, usually placing them 
beyond a single centre’s capabilities, which is why a national cross-centre initiative is required.  
Large national initiatives aggregating registry data like that led by the National Institute for 
Cardiovascular Outcomes Research (NICOR)[11] are testament to the fact linkage of national 
cardiovascular databases is feasible and has the potential for increased international comparative 
data analysis. However, NICOR infrastructure is not tailored to serve the needs of individual 
researchers aiming to conduct small-to-medium scale cardiovascular research in the cloud. The 
doctoral student with a sample size of 100 curating a 3-year project with finite funding needs 
accessible bioinformatics tools that he/she can customise and control. Electronic bioinformatics 
tools for these groups are usually limited to those provided locally by universities but such 
institutional databases are not easily accessible to collaborators in other centres. These 
investigators (sometimes junior staff) need access to secure but intuitive electronic data 
collection solutions that they can customize to the needs of their niche project. They need a 
simple but hierarchal way of controlling access, freedom to edit instruments and ease of data 
export to permit local statistical analysis.  
 
Advantages of shared infrastructures for research in the long tail 
Web-based data collection instruments have the capacity to improve the efficiency of the UK’s 
appropriately high levels of investment into cardiovascular research. A national initiative, as 
opposed to segregated single-centre university-based infrastructures, automatically creates 
dissemination standards not through imposition, but because tools will be genuinely good, easy 
to use, accessible and practically helpful.  
Cardiac research in the UK requires and receives high levels of funding to create expensive 
patient cohorts but these cohorts are typically non-standardized, partitioned to reflect the 
group’s niche expertise and data is rarely curated long term nor integrated with outcomes.  From 
concept to guideline and then through to clinical practice, takes many steps. Disseminated 
cloud-based bioinformatics broadens the range of translation that any individual research group 
can singly perform, facilitating the transition of ideas along the translational pathway (e.g. from 
single-centre cohort, to multi-centre, to outcome-studies, to standardization, to guidelines). 
Standardized data collection, growing sample size, linking to other domains of science and then 
trickling results between groups, suddenly become easy and information governance 
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strengthened. Infrastructure re-use becomes possible and new areas of research are spawned 
through linkages, previously unachievable, leading to diffused benefits. 
The release of a browser-based, flexible and secure electronic-data capture (EDC) infrastructure 
automatically encourages research groups to share (data, instruments and dictionaries). 
Expensive multi-centre UK cohort datasets may be securely accessed from any part of the 
country and robustly de-identified, standardized, curated, and merged with other sorts of data 
for maximum scientific yield. With this infrastructure of “connectedness”, collaboration is 
suddenly easier providing a sustainable route to creating large-scale cardiac data[12] and 
increasing the yields from UK research investment by accelerating the transition of a scientific 
idea into a new biomarker, clinical test or patient therapy. From scientific concept to societal 
benefit is a multistep process and network bioinformatics are needed along the pathway to 
impacts—academics may conceive ideas but teams, small-medium enterprises and 
pharmaceutical companies need to input and connect as ideas evolve.  
For research exploring the development of novel cardiac biomarkers, data sharing in the long-
tail is key as it ensures research transparency, mitigates against known biases in publication and 
increases data reuse by third parties[10]. Effect sizes need to be measured in Phase-I/II drug 
studies, but real world disease and real world biomarker performance needs to be measured for 
Phase-III and this is where unexpected trial futility is often discovered (globally, the last 20 
Phase-III trials in heart failure have been negative[13] at a waste of billions)—a potential 
“regression to the truth” as cardiac biomarkers exit the expert centres and real world data 
handling commences. Understanding and anticipating the size of this “real world effect” is hard 
without access to multi-centre, unselected pan-UK patient cohorts managed and curated using 
standardised bioinformatics tools at national level.  
 
The time is right—Important developments in UK health informatics 
The promotion of bioinformatics assets to support long-tail research in the UK coincides with 
the NHS’ growing appetite for information technology (IT) innovation and its growing focus on 
the procurement of smarter health informatics strategies. Several trusts are currently undergoing 
major transformational change and investing in ‘Health Clouds’ as funding constrictions drive 
health services to seek more efficient paperless reconfigurations, reduce complexity, improve 
data security, and drive up the quality of patient services. National bodies like the 
Commissioning Support Units and the Health and Social Care Information Centre (HSCIC) 
have been established to support this process. Healthcare clouds permit efficient electronic 
health information exchange (HIE) allowing providers to rapidly and securely access and share 
a patient’s medical information electronically but this process is dependent on data 
standardization[14]. Once standardized, the data transferred can seamlessly integrate into a 
recipients' Electronic Health Record (EHR). The Open EHR vision for UK healthcare aims to 
create life-long interoperable patient EHRs, a key-stone component of which is semantic 
interoperability[15] made possible through the CEN/ISO EN13606—a European norm for 
semantic interoperability in the EHR communication, approved by the European Committee for 
Standardization (CEN) and by the International Organization for Standardization (ISO)[16]. 
Open EHR and NHS health cloud technologies have major research ramifications—long-tail 
research instruments will be able to piggy-back onto this broader, evolving national 
infrastructure, permitting flexible spin up of resources as and when needed (“power-by-the-
hour”) and self-provisioning (studies can be containerised and rapidly deployed and re-used).  
 
Potential caveats of sharing in the long-tail 
Merging myriad datasets potentially introduces the risk of re-analysis of poor quality datasets or 
analysis of excellent datasets by non-experts using inappropriate applications, thus flooding the 
field with conflicting results[17]. There is also the financial cost and time investment involved 
in preparing data and data collection instruments to permit their use by others but shared 
standardized tools once developed will avoid this issue and deliver superior research network 
intensity. Cardiac researchers will dedicate enormous time preparing papers for publication 
driven by citation and H-index incentives, to the satisfaction of funders and to ensure survival of 
their teams and centres but the career yields from large-scale data sharing (especially of dark 
data) are not that explicit[18]. Investigators are at the mercy of the work ethic and replication 
etiquette[19] of analysing third parties, co-authorship on downstream publications may be 
sporadic, there is commonly a sense of loss of control. Furthermore, data sharing could expose 
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data errors or suboptimal reporting practices in high-impact studies many years after their 
original publication. If clinical guidelines had incorporated such data as evidence for patient 
care the implications could be devastating[20]. 
 
Example solution for shared cardioinformatics and future directions 
In a pan-UK effort to tackle the barrier to multi-centre data integration in the long-tail, starting 
with cardiology, our group has previously partnered with IT architects (not-for-profit 
organisation AIMES Grid Service Providers, www.aimes.uk) to deploy a cloud hypervisor pilot 
that provides easy-to-access bioinformatics tools for UK academics in the cardiovascular 
sciences. The primary EDC instrument used was REDCap (Research Electronic Data Capture 
[21] distributed non-commercially by Vanderbilt University for academia)—a simple 
proprietary, user-friendly, no-cost, browser-based, metadata-driven system for data collection 
and management available to academics. It has several obvious advantages over competing 
infrastructures like standard office applications (Microsoft Excel and Access) or other EDC 
systems like Open Source OpenClinicaTM. Learning OpenClnica is more difficult than for 
REDCap with fewer online training modules pages and no international Consortium to turn to 
for support; there is no project development mode so undoing or replacing fields during set-up 
is cumbersome. REDCap permits advanced customization through the use of hooks, hacks, 
application programming interfaces (API) and plugins offering a flexible way of adding micro-
features and widgets to research projects with specific user-driven requirements (e.g. our in-
house 17-segment cardiac bulls-eye plot for efficient regional wall motion scoring: 
http://www.cardioproject-redcap.org/MAPSTER/cardiocalc_wma.htm).  Another benefit is the 
ability to combine REDCap directly with R[22] through APIs which can easily export and 
import data into R, reducing the burden of data transformation and the possibility of human 
errors while streamlining the entire process of data collection, cleaning and analysis[23]. 
This UK model, committed to the usual STAndards for the Reporting of Diagnostic accuracy 
studies (STARD)[24], has been designed around the baseline skillset, aptitudes and needs of the 
everyday principal investigator and his/her junior/senior research team. Its uptake has been 
exponential due to its ease of customization and set-up efficiency particularly for junior 
academics starting a new project. It currently supports 250 UK researchers, with a total of 105 
projects actively recruiting. It is provisioned in a safe-haven environment consisting of a G-
Cloud-assured high-availability cluster with a disaster recover element existing in a separate G-
Cloud set up. Both are located within a highly secured data centre information security 
management system (ISMS) managed by AIMES and in compliance with the standards of the 
ISO/International Electrotechnical Commission and with the Health Insurance Portability and 
Accountability Act (HIPAA). AIMES is an accredited N3 cloud provider on the UK 
Government’s G-Cloud procurement framework. The platform is designed to accept the upload 
of data free of personally identifiable information deriving from research projects that already 
have the necessary ethical approvals in place. Backup power, backup servers and data restore 
facilities provisioned are fully compliant to NHS Information Governance (IG) requirements. In 
handling research data, the platform is aligned with good clinical practice and the UK Data 
Protection Act (1998). Investigators applying for grants and research ethics approval, interested 
in using this infrastructure, are provided with boilerplate verbiage outlining its data security 
features and with access to online and face-to-face EDC training sessions. Investigators using 
the platform retain responsibility for obtaining appropriate consent from participants and they 
are asked to verify this in the mandatory User Responsibility Document when registering for 
access to the system. In collaboration with professional ISMS managers at AIMES experienced 
in patient data security, IS027001 standards and the UK NHS IG Governance ISMS, we have 
established processes to ensure full respect for ethics and research governance across the pilot, 
relevant to participants and participating researchers. The pilot is currently awaiting registration 
as a database platform with the UK Research Ethics Committee. 
The vision for this pilot has grown out of extensive local experience, particularly in cardiac 
imaging—a field that is facing barriers to the clinical delivery of biomarkers because doing this 
properly requires multi-centre collaboration and integration with other data types. The on-going 
Open EHR developments coupled with advancements in Hadoop, other Apache open-source 
projects, and cloud computing,[25] offer huge opportunities to the research community—EDC 
research tools such as REDCap can be integrated and long-tail cardiac data sets mined from 
within the EHRs using big data tools rather than simply limiting the research model to data 
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collection by individual groups. It will become possible to capture niche cohort data from out of 
the larger routine clinical record but further development of electronic patient record systems in 
the NHS is required—the ultimate research objective is to permit flawless mining of the entire 
EHR in a national, secure real-time web solution that also offers complete universal follow-up 
of outcomes (linked to hospitalisation and death records etc.) by electronic surveillance. 
  
Conclusion 
Biomedical research costs will spiral in the UK if individual centres continue to build their own 
individual bioinformatics clouds instead of sharing these in a national resource, ideally with 
funding by the NHS. Expensive research eventually translates into increased tariffs for new 
therapies—reflecting a lack of understanding of basic biology, or at least the transition of that 
understanding into clinical practice.   
We are convinced that across the cardiovascular research domain, like the rest of medicine, the 
national aggregation of diverse long-tail data is the best way to convert numerous small but 
expensive cohort data sources into big data for improved knowledge. This practical and 
structured integration is achievable through a sustainable, common platform of network 
bioinformatics, breaking down translational barriers, improving research efficiency and with 
time, patient outcomes.  
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FIGURES 
Figure 1 The spectrum of research in cardiology 
Most cardiology research projects are between 20 and 1,000 subjects, typically representing also 
the middle of the translational pathway (red discontinuous box). The smallest studies may not 
necessarily need bioinformatics; the largest have funding already but are outnumbered 34:1 by 
the smaller studies. Creating cohort studies is expensive. Little bioinformatics exists to support 
them. Plot (2015) summarises lists study sizes in 300 consecutive cardiac trials registered with: 
www.clinicaltrias.gov. 
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Figure 2 Cardiac-bespoke bioinformatics platform. 
Searching the Bioinformatics Links Directory (www.bioinformatics.ca), >3,000 biomedical data 
archival platforms can be found. This plot shows the number of bioinformatics Web-servers by 
domain: absolute levels and growth over time. Using search terms for the cardiac domain 
(‘cardiology’, ‘cardiac’ and ‘cardiovascular’) it transpires that there are no servers dedicated to 
cardiac research between 2006 and 2015 (plot adapted from Cummings et al.[26]). 
 
 
